Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

- PMLiVE

TMC’s full data for inclisiran impresses at ESC

Marketing applications expected before end of year

- PMLiVE

Medimmune-born Viela files $150m IPO, eyes first product launch

Funds will help to push a number of pipeline candidates

- PMLiVE

Ardelyx gets second kidney disease trial win for tenapanor

Drug hit primary and all secondary endpoints

- PMLiVE

AZ unveils phase 3 Brilinta data in CAD and type 2 diabetes

Reduces CV events but falls down on increased bleeding risk

Roche Basel Switzerland

Roche’s flu drug Xofluza scores phase 3 primary endpoint

Demonstrates efficacy as a preventative treatment

armadillo in chains

Should there be a punishment?

I mean for people who use the word innovation willy-nilly.Is it just us here at P&P, or has the word lost its meaning? Dictionaries define it as a new idea...

Page & Page Health

- PMLiVE

Amgen takes aim at Alexion’s patents for Soliris

Follows extension of Soliris patent protection until 2027

- PMLiVE

AZ’s Farxiga heart failure results wow the ESC

Chases after market leader Jardiance

- PMLiVE

New faces at 90TEN, Lucid Group and Porterhouse

Latest movers in healthcare comms

- PMLiVE

Johnson’s move to shorten Brexit debate faces backlash

Pharma opposed to no-deal, but backs pro-industry plans

- PMLiVE

US court backs Sanofi/Regeneron in PCSK9 patent dispute with Amgen

Latest point in tit-for-tat battle between rivals

Lucid Group bolsters its senior client services team with two magical new hires

Lucid Group boosts its senior client services team with the arrival of David Pearce and Sandra Burke, both as client operational directors.With 15 years of Med Comms experience, David has...

Lucid Group Communications Limited

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links